Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma

Published: 3 December 2020| Version 1 | DOI: 10.17632/8wx2hd5twc.1
Contributor:
Kelsey Hirotsu

Description

Supplemental Figures for the article accepted to JAAD

Files

Institutions

  • Stanford University

Categories

Dermatology, Cancer, Immunotherapy

Licence